OpenSAFELY Vaccine Coverage Report
AstraZeneca / Priority Group 1
Data from combined, up to 2021-03-07.
| Vaccinated at 2021-03-07 (%) | Vaccinated at 2021-03-07 (n) | Population | Vaccinated at 2021-02-28 (%) | Vaccinated in past week (%) | ||
|---|---|---|---|---|---|---|
| Overall | - | 65.0% | 195,622 | 300,916 | 63.7% | 1.3% |
| Sex | Female | 65.7% | 125,636 | 191,233 | 64.7% | 1.0% |
| Male | 63.8% | 69,986 | 109,683 | 61.8% | 2.0% | |
| Ethnicity | White - British | 65.5% | 125,223 | 191,044 | 64.2% | 1.4% |
| White - Irish | 66.9% | 1,673 | 2,499 | 66.4% | 0.6% | |
| White - Any other White background | 56.1% | 3,521 | 6,272 | 54.7% | 1.5% | |
| Mixed - White and Black Caribbean | 55.8% | 336 | 602 | 52.3% | 3.5% | |
| Mixed - White and Black African | 47.2% | 119 | 252 | 47.2% | 0.0% | |
| Mixed - White and Asian | 60.6% | 140 | 231 | 54.5% | 6.1% | |
| Mixed - Any other mixed background | 57.4% | 273 | 476 | 52.9% | 4.4% | |
| Asian or Asian British - Indian | 61.2% | 1,260 | 2,058 | 59.5% | 1.7% | |
| Asian or Asian British - Pakistani | 51.2% | 448 | 875 | 48.8% | 2.4% | |
| Asian or Asian British - Bangladeshi | 55.9% | 231 | 413 | 50.8% | 5.1% | |
| Asian or Asian British - Any other Asian background | 56.5% | 672 | 1,190 | 54.1% | 2.4% | |
| Black or Black British - Caribbean | 55.4% | 1,260 | 2,275 | 54.2% | 1.2% | |
| Black or Black British - African | 46.3% | 651 | 1,407 | 43.8% | 2.5% | |
| Black or Black British - Any other Black background | 54.7% | 406 | 742 | 50.9% | 3.8% | |
| Other ethnic groups - Chinese | 58.0% | 203 | 350 | 54.0% | 4.0% | |
| Other ethnic groups - Any other ethnic group | 56.3% | 658 | 1,169 | 51.5% | 4.8% | |
| Patients with any other ethnicity code | 66.6% | 25,865 | 38,822 | 65.2% | 1.4% | |
| Ethnicity not stated | 63.9% | 1,757 | 2,751 | 63.1% | 0.8% | |
| Ethnicity not recorded | 65.1% | 30,828 | 47,362 | 64.2% | 0.9% | |
| Ethnicity (broad categories) | White | 65.3% | 130,424 | 199,829 | 63.9% | 1.4% |
| Mixed | 55.8% | 882 | 1,582 | 51.8% | 4.0% | |
| South Asian | 57.8% | 2,639 | 4,564 | 55.4% | 2.5% | |
| Black | 52.5% | 2,331 | 4,438 | 50.5% | 2.1% | |
| Other | 56.7% | 861 | 1,519 | 52.5% | 4.1% | |
| Unknown | 65.7% | 58,457 | 88,949 | 64.6% | 1.1% | |
| Index of Multiple Deprivation | 1 (most deprived) | 62.5% | 66,878 | 107,002 | 61.2% | 1.3% |
| 2 | 67.0% | 34,041 | 50,799 | 65.5% | 1.6% | |
| 3 | 67.7% | 34,594 | 51,121 | 66.4% | 1.3% | |
| 4 | 65.7% | 32,165 | 48,986 | 64.4% | 1.3% | |
| 5 (least deprived) | 65.3% | 26,859 | 41,153 | 64.1% | 1.1% | |
| Unknown | 58.0% | 1,064 | 1,834 | 55.3% | 2.7% | |
| Clinical Risk Groups | Patients in Any Clinical Risk Group | 66.1% | 171,325 | 259,273 | 64.7% | 1.4% |
| Patients with Immunosuppression | 64.4% | 5,894 | 9,149 | 63.1% | 1.3% | |
| Patients with CKD | 65.7% | 49,175 | 74,823 | 65.1% | 0.6% | |
| Patients who have Chronic Respiratory Disease | 65.0% | 18,109 | 27,881 | 64.0% | 0.9% | |
| Patients with Diabetes | 65.5% | 37,205 | 56,812 | 64.4% | 1.1% | |
| Patients with Chronic Liver disease | 63.7% | 4,991 | 7,840 | 61.8% | 1.9% | |
| Patients with CNS Disease (including Stroke/TIA) | 67.4% | 102,606 | 152,292 | 66.1% | 1.2% | |
| Patients with Chronic heart disease | 65.8% | 71,176 | 108,185 | 65.1% | 0.7% | |
| Patients with Asplenia or Dysfunction of the Spleen | 66.0% | 1,505 | 2,282 | 64.7% | 1.2% | |
| Patients with Wider Learning Disability | 71.2% | 32,032 | 44,968 | 67.0% | 4.2% | |
| Patients with Severe Mental Health | 63.5% | 19,061 | 30,002 | 61.3% | 2.2% | |
| Other Groups | Patients who are shielding (High Risk from COVID-19) | 66.9% | 141,582 | 211,554 | 66.2% | 0.7% |
| Patients with Morbid Obesity | 63.8% | 5,201 | 8,148 | 60.8% | 3.0% | |
| Patients who are pregnant | 21.1% | 28 | 133 | 15.8% | 5.3% |